Copyright Reports & Markets. All rights reserved.

mRNA Vaccine And Therapeutics-Global Market Status and Trend Report 2013-2023

Request for Sample of this report
Buy now

Table of Contents

    Chapter 1 Overview of mRNA Vaccine And Therapeutics

    • 1.1 Definition of mRNA Vaccine And Therapeutics in This Report
    • 1.2 Commercial Types of mRNA Vaccine And Therapeutics
      • 1.2.1 Infectious Disease
      • 1.2.2 Cancer
      • 1.2.3 Others
    • 1.3 Downstream Application of mRNA Vaccine And Therapeutics
      • 1.3.1 Hospital
      • 1.3.2 Research Institual
    • 1.4 Development History of mRNA Vaccine And Therapeutics
    • 1.5 Market Status and Trend of mRNA Vaccine And Therapeutics 2013-2023
      • 1.5.1 Global mRNA Vaccine And Therapeutics Market Status and Trend 2013-2023
      • 1.5.2 Regional mRNA Vaccine And Therapeutics Market Status and Trend 2013-2023

    Chapter 2 Global Market Status and Forecast by Regions

    • 2.1 Market Development of mRNA Vaccine And Therapeutics 2013-2017
    • 2.2 Production Market of mRNA Vaccine And Therapeutics by Regions
      • 2.2.1 Production Volume of mRNA Vaccine And Therapeutics by Regions
      • 2.2.2 Production Value of mRNA Vaccine And Therapeutics by Regions
    • 2.3 Demand Market of mRNA Vaccine And Therapeutics by Regions
    • 2.4 Production and Demand Status of mRNA Vaccine And Therapeutics by Regions
      • 2.4.1 Production and Demand Status of mRNA Vaccine And Therapeutics by Regions 2013-2017
      • 2.4.2 Import and Export Status of mRNA Vaccine And Therapeutics by Regions 2013-2017

    Chapter 3 Global Market Status and Forecast by Types

    • 3.1 Production Volume of mRNA Vaccine And Therapeutics by Types
    • 3.2 Production Value of mRNA Vaccine And Therapeutics by Types
    • 3.3 Market Forecast of mRNA Vaccine And Therapeutics by Types

    Chapter 4 Global Market Status and Forecast by Downstream Industry

    • 4.1 Demand Volume of mRNA Vaccine And Therapeutics by Downstream Industry
    • 4.2 Market Forecast of mRNA Vaccine And Therapeutics by Downstream Industry

    Chapter 5 Market Driving Factor Analysis of mRNA Vaccine And Therapeutics

    • 5.1 Global Economy Situation and Trend Overview
    • 5.2 mRNA Vaccine And Therapeutics Downstream Industry Situation and Trend Overview

    Chapter 6 mRNA Vaccine And Therapeutics Market Competition Status by Major Manufacturers

    • 6.1 Production Volume of mRNA Vaccine And Therapeutics by Major Manufacturers
    • 6.2 Production Value of mRNA Vaccine And Therapeutics by Major Manufacturers
    • 6.3 Basic Information of mRNA Vaccine And Therapeutics by Major Manufacturers
      • 6.3.1 Headquarters Location and Established Time of mRNA Vaccine And Therapeutics Major Manufacturer
      • 6.3.2 Employees and Revenue Level of mRNA Vaccine And Therapeutics Major Manufacturer
    • 6.4 Market Competition News and Trend
      • 6.4.1 Merger, Consolidation or Acquisition News
      • 6.4.2 Investment or Disinvestment News
      • 6.4.3 New Product Development and Launch

    Chapter 7 mRNA Vaccine And Therapeutics Major Manufacturers Introduction and Market Data

    • 7.1 Moderna Therapeutics
      • 7.1.1 Company profile
      • 7.1.2 Representative mRNA Vaccine And Therapeutics Product
      • 7.1.3 mRNA Vaccine And Therapeutics Sales, Revenue, Price and Gross Margin of Moderna Therapeutics
    • 7.2 Sangamo Therapeutics
      • 7.2.1 Company profile
      • 7.2.2 Representative mRNA Vaccine And Therapeutics Product
      • 7.2.3 mRNA Vaccine And Therapeutics Sales, Revenue, Price and Gross Margin of Sangamo Therapeutics
    • 7.3 eTheRNA
      • 7.3.1 Company profile
      • 7.3.2 Representative mRNA Vaccine And Therapeutics Product
      • 7.3.3 mRNA Vaccine And Therapeutics Sales, Revenue, Price and Gross Margin of eTheRNA
    • 7.4 BioNTech
      • 7.4.1 Company profile
      • 7.4.2 Representative mRNA Vaccine And Therapeutics Product
      • 7.4.3 mRNA Vaccine And Therapeutics Sales, Revenue, Price and Gross Margin of BioNTech
    • 7.5 Argos Therapeutics
      • 7.5.1 Company profile
      • 7.5.2 Representative mRNA Vaccine And Therapeutics Product
      • 7.5.3 mRNA Vaccine And Therapeutics Sales, Revenue, Price and Gross Margin of Argos Therapeutics
    • 7.6 CureVac
      • 7.6.1 Company profile
      • 7.6.2 Representative mRNA Vaccine And Therapeutics Product
      • 7.6.3 mRNA Vaccine And Therapeutics Sales, Revenue, Price and Gross Margin of CureVac
    • 7.7 Translate Bio
      • 7.7.1 Company profile
      • 7.7.2 Representative mRNA Vaccine And Therapeutics Product
      • 7.7.3 mRNA Vaccine And Therapeutics Sales, Revenue, Price and Gross Margin of Translate Bio
    • 7.8 In-Cell-Art
      • 7.8.1 Company profile
      • 7.8.2 Representative mRNA Vaccine And Therapeutics Product
      • 7.8.3 mRNA Vaccine And Therapeutics Sales, Revenue, Price and Gross Margin of In-Cell-Art
    • 7.9 Ethris
      • 7.9.1 Company profile
      • 7.9.2 Representative mRNA Vaccine And Therapeutics Product
      • 7.9.3 mRNA Vaccine And Therapeutics Sales, Revenue, Price and Gross Margin of Ethris
    • 7.10 Tiba Biotechnology
      • 7.10.1 Company profile
      • 7.10.2 Representative mRNA Vaccine And Therapeutics Product
      • 7.10.3 mRNA Vaccine And Therapeutics Sales, Revenue, Price and Gross Margin of Tiba Biotechnology

    Chapter 8 Upstream and Downstream Market Analysis of mRNA Vaccine And Therapeutics

    • 8.1 Industry Chain of mRNA Vaccine And Therapeutics
    • 8.2 Upstream Market and Representative Companies Analysis
    • 8.3 Downstream Market and Representative Companies Analysis

    Chapter 9 Cost and Gross Margin Analysis of mRNA Vaccine And Therapeutics

    • 9.1 Cost Structure Analysis of mRNA Vaccine And Therapeutics
    • 9.2 Raw Materials Cost Analysis of mRNA Vaccine And Therapeutics
    • 9.3 Labor Cost Analysis of mRNA Vaccine And Therapeutics
    • 9.4 Manufacturing Expenses Analysis of mRNA Vaccine And Therapeutics

    Chapter 10 Marketing Status Analysis of mRNA Vaccine And Therapeutics

    • 10.1 Marketing Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
      • 10.1.3 Marketing Channel Development Trend
    • 10.2 Market Positioning
      • 10.2.1 Pricing Strategy
      • 10.2.2 Brand Strategy
      • 10.2.3 Target Client
    • 10.3 Distributors/Traders List

    Chapter 11 Report Conclusion

      Chapter 12 Research Methodology and Reference

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources

      Report Summary

      mRNA Vaccine And Therapeutics-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on mRNA Vaccine And Therapeutics industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

      Worldwide and Regional Market Size of mRNA Vaccine And Therapeutics 2013-2017, and development forecast 2018-2023
      Main manufacturers/suppliers of mRNA Vaccine And Therapeutics worldwide, with company and product introduction, position in the mRNA Vaccine And Therapeutics market
      Market status and development trend of mRNA Vaccine And Therapeutics by types and applications
      Cost and profit status of mRNA Vaccine And Therapeutics, and marketing status
      Market growth drivers and challenges

      The report segments the global mRNA Vaccine And Therapeutics market as:

      Global mRNA Vaccine And Therapeutics Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
      North America
      Europe
      China
      Japan
      Rest APAC
      Latin America

      Global mRNA Vaccine And Therapeutics Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
      Infectious Disease
      Cancer
      Others

      Global mRNA Vaccine And Therapeutics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
      Hospital
      Research Institual

      Global mRNA Vaccine And Therapeutics Market: Manufacturers Segment Analysis (Company and Product introduction, mRNA Vaccine And Therapeutics Sales Volume, Revenue, Price and Gross Margin):
      Moderna Therapeutics
      Sangamo Therapeutics
      eTheRNA
      BioNTech
      Argos Therapeutics
      CureVac
      Translate Bio
      In-Cell-Art
      Ethris
      Tiba Biotechnology

      In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
      Buy now